TY - JOUR
KW - Drug Approval
KW - Erythema Nodosum
KW - Female
KW - Humans
KW - Leprostatic Agents
KW - Leprosy, lepromatous
KW - Male
KW - Thalidomide
KW - United States
KW - United States Food and Drug Administration
AU - Vanchieri C
BT - Annals of internal medicine
C1 - http://www.ncbi.nlm.nih.gov/pubmed/9446509?dopt=Abstract
DA - 1997 Nov 15
DO - 10.7326/0003-4819-127-10-199711150-00023
IS - 10
J2 - Ann. Intern. Med.
LA - eng
PY - 1997
SP - 951
EP - 2
T2 - Annals of internal medicine
TI - Preparing for thalidomide's comeback.
VL - 127
SN - 0003-4819
ER -